Search Contact
This page is available in multiple languages
Select Language

Cube Labs lists on Euronext Growth Milan Professional Segment

Back

  • 7th listing of 2023 on Euronext Growth Milan
  • Cube Labs brings the total number of companies listed on Euronext Growth Milan to 196
  • 10th listing on Euronext in 2023
  • Total placement volume of the offering equal to €4.1 million

Milan – 21 March 2023 – Borsa Italiana, part of the Euronext Group, today congratulates Cube Labs on its listing on the Professional Segment of Euronext Growth Milan.

Cube Labs is a venture builder specialising in project development in the Healthcare & Life Sciences sector. The company selects projects from promising early-stage R&D and contributes to their growth by setting up new companies, enabling innovation and turning pioneering science into healthcare solutions.

Cube Labs represents the seventh listing since the beginning of the year on Borsa Italiana’s market dedicated to small and medium-sized companies, and it brings the total number of firms currently listed on Euronext Growth Milan to 196.

In the placement phase, Cube Labs raised €4.1 million. The free float at the time of admission was 12.04% and the market capitalisation at IPO was €34.1 million.

Filippo Surace, CEO and Founder of Cube Labs, said: “The listing of Cube Labs on Euronext Growth Milan represents a historic moment, because today Italian academic research enters into the capital market with an innovative business model. Today's listing will enable Cube Labs to grow and establish a unique model based on the cutting-edge research and technologies developed by the companies in our portfolio. This is in the rapidly evolving Life Science sector, which represents the new frontier of healthcare in Italy and the world. We have received positive feedback from professional investors, indicating that our access to the stock market will support Cube Labs’ growth strategy, particularly at an international level. This includes leveraging our network in the academic world to create science companies in the biotech and medtech sectors through an innovative public-private technology transfer model. Our ultimate goal is to facilitate the commercial development of scientific research projects in markets with high growth potential.”

Cube Labs

Caption Filippo Surace, Chairman and CEO of Cube Labs, Massimo Fiocchi, CFO and Board Member of Cube Labs, and Renato Del Grosso, Chief Strategy Officer and Board Member of Cube Labs, rang the bell during the market open ceremony this morning to celebrate the Initial Public Offering of the company.

About Cube Labs S.p.A.

Cube Labs is the Italian venture builder in the healthcare technology sector, created to bridge the gap between excellent academic science and the commercial Life Science market. Cube Labs creates new companies from commercially promising R&D and promotes innovation to transform pioneering science into healthcare solutions. Through its international network, Cube Labs collaborates with innovation stakeholders to transform outcomes for patients and accelerate the global transition to optimal health. For more information, please visit the website: www.cube-labs.com

Download the PR - Cube Labs lists on Euronext Growth Milan Professional Segment

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With nearly 1,900 listed issuers and around €6.3 trillion in market capitalisation as of end September 2024, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2024, Euronext N.V. - All rights reserved.